Immuron Ltd (IMRN) income statement
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.90+0.05 (+5.86%)
Close on Nov 20, 2026Market cap $7.26MP/E –Yield –
Immuron Ltd financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $7.26MP/E –Yield –
See a number that looks wrong?
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | 64.5% | 65.4% | 68.1% | 72.5% | 68.4% | 65.0% | 72.6% | 72.0% | 97.8% | 75.8% | 69.9% | – |
| Operating margin | -49.9% | -73.3% | -118.3% | -197.8% | -375.0% | -5,748.5% | -115.4% | -195.0% | -209.0% | -481.5% | – | – |
| EBITDA margin | -49.4% | -72.7% | -117.4% | -195.1% | -371.6% | -5,718.5% | -113.6% | -194.8% | -208.7% | -481.2% | – | – |
| Pre-tax margin | -47.7% | -71.6% | -141.5% | -209.8% | -373.0% | -5,751.6% | -116.2% | -195.0% | -210.6% | -487.3% | -706.1% | – |
| Net profit margin | -47.7% | -71.6% | -141.5% | -209.8% | -373.0% | -5,751.6% | -116.2% | -195.0% | – | – | – | – |
| Free cash flow margin | -42.3% | – | -119.9% | -144.2% | -412.7% | -2,802.5% | -125.0% | -75.4% | -241.0% | -497.6% | -515.5% | – |
| Returns on capital | ||||||||||||
| Return on equity | -38.3% | -50.2% | -42.9% | -17.7% | -11.6% | -53.2% | -45.1% | -59.0% | – | – | – | – |
| Return on assets | -31.6% | -40.6% | -37.0% | -16.2% | -11.0% | -50.4% | -39.7% | -52.3% | – | – | – | – |
| Return on tangible assets | -31.6% | -40.6% | -37.0% | -16.2% | -11.0% | -50.4% | -39.7% | -52.3% | – | – | – | – |
| Return on invested capital | – | – | – | – | – | – | – | – | – | -195.3% | – | – |
| Return on capital employed | -39.4% | -50.9% | -35.6% | -16.6% | -11.6% | -53.0% | -44.5% | -58.9% | -40.6% | -98.2% | – | – |
| Return on total capital | – | – | – | – | – | – | – | – | – | -100.1% | – | – |
| NOPAT | -3.04M | -4.22M | -4.58M | -2.82M | -2.27M | -6.62M | -2.30M | -3.68M | -2.41M | -5.31M | – | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -42.3% | -84.2% | -119.9% | -143.8% | -411.4% | -2,798.0% | -125.0% | -75.3% | -240.5% | -497.2% | -515.3% | – |
| OCF / Net income | 0.89 | 1.18 | 0.85 | 0.69 | 1.10 | 0.49 | 1.08 | 0.39 | – | – | – | – |
| FCF / OCF | 100.1% | – | 100.0% | 100.3% | 100.3% | 100.2% | 100.0% | 100.1% | 100.2% | 100.1% | 100.0% | – |
| FCF / Net income | 0.89 | – | 0.85 | 0.69 | 1.11 | 0.49 | 1.08 | 0.39 | – | – | – | – |
| FCF / EBITDA | 85.7% | – | 102.2% | 73.9% | 111.1% | 49.0% | 110.0% | 38.7% | 115.5% | 103.4% | – | – |
| Unlevered free cash flow | -3.25M | – | -5.87M | -2.60M | -3.15M | -4.07M | -3.13M | -1.80M | -3.49M | -6.88M | -4.89M | – |
| Levered free cash flow | -3.26M | – | -5.88M | -2.60M | -3.16M | -4.09M | -3.15M | -1.80M | -3.51M | -6.95M | -5.16M | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.66 | 0.57 | 0.26 | 0.08 | 0.03 | 0.01 | 0.34 | 0.27 | 0.17 | 0.16 | 0.11 | – |
| Fixed asset turnover | 795.26 | 88.64 | 27.66 | 8.46 | 5.88 | 2.79 | 57.30 | 127.25 | 74.29 | 74.12 | – | – |
| Receivables turnover | 4.63 | 4.40 | 5.43 | 3.34 | 1.53 | 0.44 | 3.88 | 1.80 | 0.84 | 0.79 | – | – |
| Days sales outstanding | 78.9 | 83.0 | 67.2 | 109.2 | 237.9 | 829.3 | 94.0 | 202.7 | 432.4 | 462.3 | – | – |
| Payables turnover | 1.91 | 1.38 | 0.94 | 0.42 | 0.25 | 0.09 | 0.93 | 0.75 | 0.42 | 0.26 | – | – |
| Days payables outstanding | 191.6 | 265.2 | 387.9 | 866.8 | 1,449.3 | 4,084.1 | 391.1 | 487.1 | 862.9 | 1,395.3 | – | – |
| Inventory turnover | 1.35 | 1.50 | 1.29 | 0.85 | 0.78 | 0.09 | 1.03 | 1.28 | 0.30 | 0.14 | – | – |
| Days inventory outstanding | 269.6 | 242.9 | 282.5 | 429.6 | 467.5 | 3,895.9 | 355.6 | 285.0 | 1,235.3 | 2,526.1 | – | – |
| Operating cycle | 348.5 | 325.9 | 349.7 | 538.9 | 705.4 | 4,725.1 | 449.5 | 487.8 | 1,667.7 | 2,988.4 | – | – |
| Cash conversion cycle | 157.0 | 60.7 | -38.2 | -327.9 | -743.9 | 641.1 | 58.4 | 0.7 | 804.7 | 1,593.1 | – | – |
| CapEx to revenue | 0.06% | – | 0.00% | 0.43% | 1.3% | 4.5% | 0.03% | 0.09% | 0.45% | 0.41% | 0.24% | – |
| CapEx to OCF | -0.15% | – | -0.00% | -0.30% | -0.32% | -0.16% | -0.03% | -0.11% | -0.19% | -0.08% | -0.05% | – |
| CapEx to depreciation | 0.11 | – | 0.00 | 0.16 | 0.38 | 0.15 | 0.02 | 0.39 | 1.31 | 1.16 | 0.63 | – |
| Liquidity | ||||||||||||
| Current ratio | 7.26 | 5.09 | 5.46 | 9.20 | 15.75 | 22.96 | 8.54 | 5.59 | 8.78 | 4.83 | – | – |
| Quick ratio | 5.98 | 4.19 | 4.87 | 8.82 | 15.53 | 22.69 | 6.99 | 5.13 | 8.16 | 3.47 | – | – |
| Cash ratio | 5.05 | 1.44 | 4.32 | 7.73 | 14.71 | 22.33 | 6.29 | 4.28 | 5.88 | 2.33 | – | – |
| Working capital | 11.17M | 8.05M | 12.03M | 18.19M | 22.17M | 24.63M | 3.89M | 5.49M | 6.25M | 6.56M | – | – |
| Net current asset value | 10.97M | 7.95M | 11.89M | 18.04M | 21.99M | 24.59M | 3.85M | 5.47M | 6.25M | 6.56M | – | – |
| Leverage | ||||||||||||
| Total debt | – | – | – | – | – | – | – | – | – | 139.86K | – | – |
| Net debt | – | – | – | – | – | – | – | – | – | -3.86M | – | – |
| Debt / Equity | – | – | – | – | – | – | – | – | – | 0.02 | – | – |
| Debt ratio | – | – | – | – | – | – | – | – | – | 1.7% | – | – |
| Assets to equity | 1.18 | 1.26 | 1.22 | 1.12 | 1.07 | 1.04 | 1.10 | 1.16 | 1.10 | 1.26 | – | – |
| Total debt / Capitalization | – | – | – | – | – | – | – | – | – | 2.1% | – | – |
| Net debt / EBITDA | – | – | – | – | – | – | – | – | – | 0.57 | – | – |
| Total debt / EBITDA | – | – | – | – | – | – | – | – | – | -0.02 | – | – |
| Cash flow to debt | – | – | – | – | – | – | – | – | – | -4,963.7% | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -261.74 | -731.63 | -765.72 | -369.75 | -464.08 | -608.96 | -134.32 | – | -125.86 | -74.99 | – | – |
| EBITDA / Interest expense | -258.86 | -724.83 | -759.65 | -364.71 | -459.77 | -605.79 | -132.29 | – | -125.65 | -74.93 | – | – |
| (EBITDA − CapEx) / Interest expense | -259.19 | – | -759.68 | -365.51 | -461.40 | -606.27 | -132.33 | – | -125.92 | -75.00 | – | – |
| Per share | ||||||||||||
| Revenue per share | 0.03 | 0.03 | 0.02 | 103,126.00 | 0.0034 | – | – | – | 0.01 | 0.02 | 0.01 | – |
| EPS (basic) | -1.24 | -2.26 | -3.04 | -1.66 | -1.25 | -3.79 | -1.66 | -3.22 | -2.30 | -6.40 | 9.25 | – |
| EPS (diluted) | -1.24 | -2.26 | -3.04 | -1.66 | -1.25 | -3.79 | -1.66 | -3.22 | -2.30 | -6.40 | 9.25 | – |
| Book value per share | 0.04 | 0.03 | 0.06 | 1,120,962.06 | 0.10 | – | – | – | 0.06 | 0.08 | – | – |
| Tangible book value per share | 0.04 | 0.03 | 0.06 | 1,120,962.06 | 0.10 | – | – | – | 0.06 | 0.08 | – | – |
| Cash per share | 0.03 | 0.01 | 0.05 | 980,557.94 | 0.10 | – | – | – | 0.04 | 0.05 | 0.03 | – |
| Operating cash flow per share | -0.01 | -0.03 | -0.03 | -148,296.86 | -0.01 | – | – | – | -0.03 | -0.09 | -0.07 | – |
| Free cash flow per share | -0.01 | – | -0.03 | -148,739.09 | -0.01 | – | – | – | -0.03 | -0.09 | -0.07 | – |
| CapEx per share | 0.0000 | – | 0.0000 | 442.23 | 0.0000 | – | – | – | 0.0001 | 0.0001 | 0.0000 | – |
| Valuation at period end | ||||||||||||
| Market cap | 6.12M | 9.91M | 1 | 11.49M | – | – | – | 10.37M | 20.34M | 16.12M | – | – |
| Enterprise value | 4.16M | 2.25M | -11.46M | -3.24M | – | – | – | 7.06M | 17.49M | 14.36M | – | – |
| P/S | 0.8x | 1.4x | 0.0x | 6.4x | – | – | – | 4.3x | 14.0x | 11.5x | – | – |
| P/B | 0.5x | 1.2x | 0.0x | 0.6x | – | – | – | 1.4x | 2.4x | 2.5x | – | – |
| P/TBV | 0.5x | 1.2x | 0.0x | 0.6x | – | – | – | 1.4x | 2.4x | 2.5x | – | – |
| P/Gross profit | 1.2x | 2.1x | 0.0x | 8.8x | – | – | – | 6.0x | 14.3x | 15.2x | – | – |
| P/OCF | -1.9x | -1.6x | -0.0x | -4.4x | – | – | – | -5.8x | -5.8x | -2.3x | – | – |
| EV/Sales | 0.5x | 0.3x | -2.3x | -1.8x | – | – | – | 3.0x | 12.0x | 10.3x | – | – |
| EV/Gross profit | 0.8x | 0.5x | -3.4x | -2.5x | – | – | – | 4.1x | 12.3x | 13.6x | – | – |
| EV/EBITDA | – | – | 2.0x | 0.9x | – | – | – | – | – | – | – | – |
| EV/EBIT | – | – | 2.0x | 0.9x | – | – | – | – | – | – | – | – |
| EV/OCF | -1.3x | -0.4x | 1.9x | 1.2x | – | – | – | -3.9x | -5.0x | -2.1x | – | – |
| EV/FCF | – | – | 1.9x | 1.2x | – | – | – | – | – | – | – | – |
| Earnings yield | -60.1% | -52.6% | -693,695,700.0% | -32.9% | – | – | – | -44.9% | – | – | – | – |
| FCF yield | -53.3% | – | -588,033,400.0% | -22.6% | – | – | – | -17.4% | -17.3% | -43.1% | – | – |
| Shareholder yield | ||||||||||||
| Debt paydown yield | – | – | – | – | – | – | – | – | 1.8% | 10.5% | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 25.1% | 49.4% | 109.6% | 143.6% | 86.0% | 937.8% | 46.8% | 43.8% | 154.9% | 331.7% | 362.0% | – |
| SG&A to revenue | – | – | – | – | – | 2,926.7% | 181.7% | 191.0% | 19.4% | 29.2% | 13.4% | – |
| Stock-based comp to revenue | 1.1% | 4.2% | 0.07% | 12.6% | 12.4% | – | 2.9% | 56.3% | 4.1% | 37.4% | -207.7% | – |
| Per employee | ||||||||||||
| Total employees | 7 | 7 | 6 | 6 | 5 | 4 | 5 | 6 | 7 | 7 | 7 | 7 |
| Revenue per employee | 1.10M | 1.04M | 817.14K | 300.78K | 153.04K | 36.44K | 503.71K | 397.90K | 208.13K | 199.46K | 143.01K | – |
| Gross profit per employee | 710.72K | 680.73K | 556.13K | 218.19K | 104.70K | 23.68K | 365.95K | 286.68K | 203.46K | 151.24K | 99.95K | – |
| Operating profit per employee | -550.10K | -763.51K | -966.85K | -594.81K | -573.97K | -2.09M | -581.12K | -776.08K | -435.09K | -960.41K | – | – |
| Net income per employee | -525.71K | -745.14K | -1.16M | -631.08K | -570.85K | -2.10M | -585.44K | -776.07K | – | – | – | – |
| Free cash flow per employee | -466.35K | – | -980.06K | -433.82K | -631.57K | -1.02M | -629.64K | -300.10K | -501.59K | -992.59K | -737.25K | – |
| Growth | ||||||||||||
| Revenue 1Y growth | 5.9% | 48.6% | 171.7% | 135.8% | 424.9% | -94.2% | 5.5% | 63.9% | 4.3% | 39.5% | – | – |
| Revenue 3Y CAGR | 62.3% | 112.0% | 222.8% | -10.5% | -31.6% | -53.6% | 21.7% | 33.6% | – | – | – | – |
| Revenue 5Y CAGR | 121.2% | 23.7% | 15.5% | 4.4% | -11.3% | -32.0% | – | – | – | – | – | – |
| Revenue 10Y CAGR | 22.7% | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | 4.4% | 42.8% | 154.9% | 150.1% | 452.8% | -94.8% | 6.4% | 20.8% | 34.5% | 51.3% | – | – |
| Gross profit 3Y CAGR | 56.1% | 108.8% | 227.8% | -10.6% | -32.7% | -59.5% | 20.0% | 35.0% | – | – | – | – |
| Gross profit 5Y CAGR | 120.8% | 21.1% | 14.2% | -1.7% | -13.1% | -33.0% | – | – | – | – | – | – |
| Gross profit 10Y CAGR | 21.7% | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 28.0% | 7.9% | -62.5% | -24.4% | 65.8% | -188.4% | 37.6% | -52.9% | 54.7% | – | – | – |
| EBITDA 1Y growth | 28.1% | 8.0% | -63.5% | -23.8% | 65.9% | -191.3% | 38.5% | -53.0% | 54.7% | – | – | – |
| Net income 1Y growth | 29.4% | 24.8% | -83.2% | -32.7% | 66.0% | -186.4% | 37.1% | – | – | – | – | – |
| Diluted EPS 1Y growth | 45.1% | 25.7% | -83.1% | -32.8% | 67.0% | -128.3% | 48.4% | -40.0% | 64.1% | -169.2% | – | – |
| Operating cash flow 1Y growth | 46.9% | -4.4% | -126.6% | 17.6% | 22.8% | -29.6% | -75.0% | 48.7% | 49.5% | -34.6% | – | – |
| Free cash flow 1Y growth | – | – | -125.9% | 17.6% | 22.7% | -29.8% | -74.8% | 48.7% | 49.5% | -34.6% | – | – |
| CapEx 1Y growth | – | – | -97.5% | -23.0% | 51.6% | 667.4% | -57.8% | -69.0% | 15.8% | 133.3% | – | – |
| CapEx 3Y CAGR | -15.0% | – | -69.1% | 107.7% | 69.9% | 0.18% | -46.7% | -5.7% | – | – | – | – |
| CapEx 5Y CAGR | -6.4% | – | -37.5% | 3.3% | 12.0% | 22.1% | – | – | – | – | – | – |
| CapEx 10Y CAGR | 6.9% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 29.8% | -34.9% | -29.3% | -11.5% | -8.1% | 336.2% | -27.6% | -7.4% | 11.5% | -6.1% | – | – |
| Total assets 3Y CAGR | -15.7% | -25.9% | -16.9% | 52.5% | 42.7% | 43.0% | -9.2% | -1.0% | – | – | – | – |
| Total assets 5Y CAGR | -13.4% | 10.3% | 12.7% | 18.9% | 24.6% | 25.1% | – | – | – | – | – | – |
| Total assets 10Y CAGR | 4.1% | – | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.